Emmanuelle Charpentier | |
---|---|
Born | Emmanuelle Marie Charpentier 11 December 1968 Juvisy-sur-Orge, France |
Education | Pierre and Marie Curie University (BSc, MSc, PhD) |
Known for | CRISPR[1] |
Awards |
|
Scientific career | |
Fields | |
Institutions | University of Berlin University of Vienna Umeå University Max Planck Society |
Thesis | Antibiotic resistance in Listeria spp (1995) |
Doctoral advisor | Patrice Courvalin |
Website | www |
Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968[2]) is a French professor and researcher in microbiology, genetics, and biochemistry.[1] As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens.[3] In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR). This was the first science Nobel Prize ever won by two women only.[4][5][6]